Is ¹⁸F-FDG PET/CT Useful for the Early Prediction of Histopathologic Response to Neoadjuvant Erlotinib in Patients with Non-Small Cell Lung Cancer?

Autor: Aukema, Tjeerd S., Kappers, Ingrid, Olmos, Renato A. Valde's, Codrington, Henk E., van Tinteren, Harm, van Pel, Reneé, Klomp, Houke M.

Publikováno v: Journal of Nuclear Medicine; Sep2010, Vol. 51 Issue 9, p1344-1348, 5p, 1 Color Photograph, 1 Chart, 1 Graph